These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19551359)

  • 1. Enzyme assay design for high-throughput screening.
    Williams KP; Scott JE
    Methods Mol Biol; 2009; 565():107-26. PubMed ID: 19551359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of uniform-well readouts.
    Josiah S
    Methods Mol Biol; 2009; 486():177-92. PubMed ID: 19347624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction: cell-based assays for high-throughput screening.
    An WF; Tolliday NJ
    Methods Mol Biol; 2009; 486():1-12. PubMed ID: 19347612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease, and 1 phosphatase.
    Turek-Etienne TC; Small EC; Soh SC; Xin TA; Gaitonde PV; Barrabee EB; Hart RF; Bryant RW
    J Biomol Screen; 2003 Apr; 8(2):176-84. PubMed ID: 12844438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Readout technologies for highly miniaturized kinase assays applicable to high-throughput screening in a 1536-well format.
    Klumpp M; Boettcher A; Becker D; Meder G; Blank J; Leder L; Forstner M; Ottl J; Mayr LM
    J Biomol Screen; 2006 Sep; 11(6):617-33. PubMed ID: 16760365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and implementation of high-throughput screening assays.
    Macarrón R; Hertzberg RP
    Methods Mol Biol; 2009; 565():1-32. PubMed ID: 19551355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanodroplet microarrays for high-throughput enzyme screening.
    Aw KL; Yao SQ; Uttamchandani M
    Methods Mol Biol; 2010; 669():79-93. PubMed ID: 20857359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput generation of selected reaction-monitoring assays for proteins and proteomes.
    Picotti P; Rinner O; Stallmach R; Dautel F; Farrah T; Domon B; Wenschuh H; Aebersold R
    Nat Methods; 2010 Jan; 7(1):43-6. PubMed ID: 19966807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A FRET-based assay platform for ultra-high density drug screening of protein kinases and phosphatases.
    Rodems SM; Hamman BD; Lin C; Zhao J; Shah S; Heidary D; Makings L; Stack JH; Pollok BA
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):9-19. PubMed ID: 15090152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
    Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
    J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and implementation of high throughput screening assays.
    Macarrón R; Hertzberg RP
    Methods Mol Biol; 2002; 190():1-29. PubMed ID: 12029816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists.
    Golla R; Seethala R
    J Biomol Screen; 2002 Dec; 7(6):515-25. PubMed ID: 14599349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating real-life high-throughput screening data.
    Gribbon P; Lyons R; Laflin P; Bradley J; Chambers C; Williams BS; Keighley W; Sewing A
    J Biomol Screen; 2005 Mar; 10(2):99-107. PubMed ID: 15799953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
    Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
    J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-based assays.
    An WF
    Methods Mol Biol; 2009; 486():97-107. PubMed ID: 19347618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening assays for the identification of chemical probes.
    Inglese J; Johnson RL; Simeonov A; Xia M; Zheng W; Austin CP; Auld DS
    Nat Chem Biol; 2007 Aug; 3(8):466-79. PubMed ID: 17637779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of substrate-induced quenching for screening targets promoting NADH and NADPH consumption.
    Vázquez MJ; Ashman S; Ramón F; Calvo D; Bardera A; Martín JJ; Rüdiger M; Tew D; Domínguez JM
    J Biomol Screen; 2006 Feb; 11(1):75-81. PubMed ID: 16361697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.